Rho Capital Partners

Latest statistics and disclosures from RHO CAPITAL PARTNERS's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Anacor Pharmaceuticals In, IL, Cara Therapeutics, Everyday Health, Inotek Pharmaceuticals. These five stock positions account for 93.16% of RHO CAPITAL PARTNERS's total stock portfolio.
  • Reduced shares in these 1 stocks: IL.
  • As of Sept. 30, 2015, RHO CAPITAL PARTNERS has $301.09M in assets under management (AUM). Assets under management grew from a total value of $286.00M to $301.09M.
  • Independent of market fluctuations, RHO CAPITAL PARTNERS was a net seller by $1.66M worth of stocks in the most recent quarter.

RHO CAPITAL PARTNERS portfolio companies for September 2015 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
Anacor Pharmaceuticals In 41.75 1067892 117.71 0.00
IL IntraLinks Holdings 17.32 -3.00% 6290503 8.29 10.29
Cara Therapeutics 12.66 2668057 14.29 0.00
Everyday Health 12.47 4107522 9.14 0.00
Inotek Pharmaceuticals 8.96 2870584 9.40 0.00
Rubicon Proj 3.85 798381 14.53 0.00
RLOC ReachLocal 1.80 2570395 2.11 3.08
Nephrogenex 1.18 1052966 3.38 0.00

Past 13F-HR SEC Filings for RHO CAPITAL PARTNERS

View All Filings for RHO CAPITAL PARTNERS